GSK3B and Alzheimer disease: Analysis showed that the evasion latency time in the curcumin group was significantly increased, the number of crossing platforms was reduced (p < 0.05), and the expression of GSK3β protein in the hippocampus was reduced, thus significantly ameliorating neuronal cell damage in the rat model of AD.